These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16627248)

  • 1. Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene.
    Metzler M; Mann G; Monschein U; Lodzinski M; Gall C; Flohr T; Viehmann S; Langer T; Schrappe M; Gadner H; Haas OA; Panzer-Grümayer ER
    Haematologica; 2006 May; 91(5):683-6. PubMed ID: 16627248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients.
    Brassesco MS; Camparoto ML; Tone LG; Sakamoto-Hojo ET
    Cytogenet Genome Res; 2004; 104(1-4):346-51. PubMed ID: 15162063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
    Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
    Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia.
    Hjalgrim LL; Madsen HO; Melbye M; Jørgensen P; Christiansen M; Andersen MT; Pallisgaard N; Hokland P; Clausen N; Ryder LP; Schmiegelow K; Hjalgrim H
    Br J Cancer; 2002 Oct; 87(9):994-9. PubMed ID: 12434291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenting features of 201 children with acute lymphoblastic leukemia: comparison according to presence or absence of ETV6/RUNX1 rearrangement.
    Alvarez Y; Caballín MR; Gaitán S; Pérez A; Bastida P; Ortega JJ; Cervera J; Verdeguer A; Tasso M; Aventín A; Badell I; Guitart M; Melo M; Granada I; Javier G; Dastugue N; Robert A; Coll MD
    Cancer Genet Cytogenet; 2007 Sep; 177(2):161-3. PubMed ID: 17854676
    [No Abstract]   [Full Text] [Related]  

  • 6. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.
    Konrad M; Metzler M; Panzer S; Ostreicher I; Peham M; Repp R; Haas OA; Gadner H; Panzer-Grumayer ER
    Blood; 2003 May; 101(9):3635-40. PubMed ID: 12506024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia.
    Hoffmann J; Krumbholz M; Gutiérrez HP; Fillies M; Szymansky A; Bleckmann K; Zur Stadt U; Köhler R; Kuiper RP; Horstmann M; von Stackelberg A; Eckert C; Metzler M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27780. PubMed ID: 31034759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
    Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
    Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Calasanz MJ; Garate L; San Jose-Eneriz E; Cordeu L; Prosper F; Heiniger A; Torres A
    Clin Cancer Res; 2006 Aug; 12(16):4845-50. PubMed ID: 16914570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of early precursors of t(12;21) positive pediatric acute lymphoblastic leukemia during follow-up.
    László R; Alpár D; Kajtár B; Lacza A; Ottóffy G; Kiss C; Bartyik K; Nagy K; Pajor L
    Pediatr Blood Cancer; 2010 Jan; 54(1):158-60. PubMed ID: 19813247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia.
    Al-Shehhi H; Konn ZJ; Schwab CJ; Erhorn A; Barber KE; Wright SL; Gabriel AS; Harrison CJ; Moorman AV
    Genes Chromosomes Cancer; 2013 Feb; 52(2):202-13. PubMed ID: 23077088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia.
    von Goessel H; Jacobs U; Semper S; Krumbholz M; Langer T; Keller T; Schrauder A; van der Velden VH; van Dongen JJ; Harbott J; Panzer-Grümayer ER; Schrappe M; Rascher W; Metzler M
    Leuk Res; 2009 Aug; 33(8):1082-8. PubMed ID: 19081626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophagocytosis by leukemic blasts in B lymphoblastic leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1): a case report.
    Park JE; Park IJ; Lim YA; Lee WG; Cho SR
    Ann Clin Lab Sci; 2013; 43(2):186-9. PubMed ID: 23694795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.
    Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ;
    Br J Haematol; 2008 Mar; 140(6):665-72. PubMed ID: 18241254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal variation of the immunogenotype in relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development.
    Peham M; Konrad M; Harbott J; König M; Haas OA; Panzer-Grümayer ER
    Genes Chromosomes Cancer; 2004 Feb; 39(2):156-60. PubMed ID: 14695996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].
    Raciborska A; Wypych A; Rokicka-Milewska R; Siedlecki JA; Kulik J
    Przegl Lek; 2004; 61 Suppl 2():62-6. PubMed ID: 15686049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique variant of ETV6/AML1 fusion in a child with acute lymphoblastic leukemia.
    Jalali GR; Martineau M; Ford AM; Greaves M; Stevens RF; Harrison CJ
    Leukemia; 2003 May; 17(5):993-5. PubMed ID: 12750722
    [No Abstract]   [Full Text] [Related]  

  • 20. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
    Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
    Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.